Comment on "PP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL human leukemia".
Odero, Maria D.
Ruvolo, Peter P.
Verrills, Nicole M.
MetadataShow full item record
AbstractLB100 does not sensitize CML stem cells to tyrosine kinase inhibitor-induced apoptosis. [Abstract copyright: Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.]
CitationScience translational medicine, volume 11, issue 501
DescriptionFrom PubMed via Jisc Publications Router
History: received 2018-05-01, accepted 2019-05-09
Publication status: ppublish